Product Description
Tiragolumab (TIGIT/VSIG9/VSTM3) Antibody, Monoclonal | 10-856 | ProSci
Host: N/A
Reactivity: N/A
Homology: N/A
Immunogen: Homo sapiens / TIGIT/VSIG9/VSTM3 [Homo sapiens]
Research Area: Drug Analogues
Tested Application: N/A
Application: N/A
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: >95%
Clonality: Monoclonal
Clone: N/A
Isotype: IgG1-kappa
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS buffer pH7.5
Concentration: N/A
Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚C for 1-2 weeks. Store at -20 ˚C for 12 months. Store at -80 ˚C for long term storage.
Alternate Name: MTIG-7192-A, MTIG-7192A, MTIG7192A, RG-6058, RO-7092284, RO7092284
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Tiragolumab is fully humanized monoclonal antibody. Tiragolumab targets TIGIT and directly or indirectly activates anti-tumor immune responses by acting on the activation pathways of APC and T cells and NK cells to achieve the purpose of eliminating tumor cells.